(NYSE: PFE), (NASDAQ: FEED), (OTCBB: GSPG).

RealPennies.com: Turning Pennies into dollars: (NYSE: PFE), (NASDAQ: FEED), (OTCBB: GSPG).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559


For more info: http://pfe.realpennies.com

Pfizer (NYSE: PFE)(January 29, 2008), headquartered in Shibuya-ku, Tokyo, which is engaged in the development, production, marketing and sales of healthcare products, announced on 28 January that the company has received manufacturing and marketing authorization for Champix Tablet 0.5 mg/1mg (varenicline tartrate). Champix is reportedly Japan's first oral smoking cessation aid developed for smoking cessation treatment for smokers dependent on nicotine.

The company said Champix brings about a smoking cessation effect as a non-nicotine partial agonist that binds to nicotine receptors in the brain with strong affinity. According to the company, Champix acts as an agonist for nicotine receptors in the brain, which are associated with nicotine dependence, relieving withdrawal symptoms and tobacco craving associated with smoking cessation. It claimed that if a person smokes a cigarette while receiving treatment, Champix acts as an antagonist to inhibit nicotine from binding to the nicotine receptors and restricts the patient's sense of satisfaction associated with smoking.

The company stated that in a 12-week, randomized, double-blind, placebo-controlled study in Japanese smokers wanting to stop smoking, the primary endpoint (thef our consecutive-week smoking cessation rate between Week nine and Week 12) was 65.4% (85/130 cases) in patients receiving 1mg Champix twice-daily and 39.5% in the placebo group (51/129 cases) respectively, showing a significant difference between the two groups, statistically.

For more info: http://feed.realpennies.com

AgFeed Industries, Inc. (NASDAQ: FEED) (January 29, 2008), a market leader in China's premix animal nutrition and hog raising industry, announces today that the Chinese government has designated the hog raising sector as an income tax exempt industry due to hog shortage and the government's policy that helps hog farmers generate greater incomes. Unless exemptions are available by law, China has a flat corporate tax rate of 25% on earnings.

Songyan Li, PhD, AgFeed's Chairman commented: "In 2007, AgFeed experienced record earnings growth from our premix feed business. In 2008, we expect to derive the majority of our revenues from the hog raising business while we continue to expect high growth in our feed segment. Management believes that AgFeed will benefit from record high hog prices in 2008 due to rising consumer income levels and estimated strong demand for premium priced lean and safe meat associated with the coming Olympic Games. We are currently selling our meat hogs at approximately $221 each with average net income margin of approximately 37%, before deducting minority interest, from our majority owned (51% to 100% ownership) hog farms. AgFeed is currently on track to produce 120,000 hogs this year. We target total production of 400,000 hogs in 2008 through acquisitions of existing producing hog farms at low single digit, 2008 P/E valuation. AgFeed looks forward to another year of record earnings growth in 2008."

According to the China Feed Industry Association, over 530 million hogs are raised in China each year compared to approximately 100 million in the US. Pork represents approximately 65% of all meat consumption in China. Approximately 70% of China's annual hog production is contributed by individual hog farmers in a highly fragmented market represented by China's 500 million farmers that rely on animal raising and field output for incomes.

For more info: http://gspg.realpennies.com

GoldSpring, Inc. (OTCBB: GSPG)(January 29, 2008), announced that early assay results from Stage One drilling at the Company's Comstock Lode Project are encouraging. The assays are being conducted by American Labs, an independent testing firm. The Company expects to receive a complete report from the lab within the next four business days. GoldSpring intends to release the results of the assays after the completed report had been received and reviewed.

Read our full disclaimer at: http://www.realpennies.com/start.html
Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

RealPennies .
Telephone: 1-800-940-6559
Matt /at/ realpennies.com